Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Ardelyx divulges glycyrrhetinic derivatives for hyperkalemia

Sep. 1, 2020

Taisho Pharmaceutical discloses new 20-HETE synthase inhibitors

Aug. 31, 2020

Evotec and Novo Nordisk collaborate to develop novel therapies for CKD

Aug. 19, 2020

AstraZeneca is enrolling participants in phase I study of MEDI-8367

Aug. 7, 2020

Positive topline data presented from phase IIa ACTION study of DMX-200 in FSGS

July 30, 2020

Phase III DAPA-CKD trial of Farxiga meets all primary and secondary endpoints

July 28, 2020

Metabolic reprogramming promotes ADPKD cystogenesis

July 22, 2020

Goldfinch Bio begins phase IIa study of GFB-887 for renal diseases

July 21, 2020

Apolipoprotein L1 inhibitors discovered at Vertex Pharmaceuticals

July 15, 2020

Phase III FIDELIO-DKD study of finerenone meets primary endpoint

July 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...